You can buy or sell DOVA and other stocks, options, ETFs, and crypto commission-free!
Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Read More Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC.
Durham, North Carolina
52 Week High
52 Week Low
Expected Nov 7, Pre-Market